These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12589144)

  • 1. Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
    Junghanss C; Takatu A; Little MT; Maciej Zaucha J; Zellmer E; Yunusov M; Sale G; Georges GE; Storb R
    Transplantation; 2003 Feb; 75(3):268-74. PubMed ID: 12589144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs.
    Georges GE; Storb R; Maciej Zaucha J; Taranova AG; Gooley T; Nash RA
    Bone Marrow Transplant; 2003 Jun; 31(11):1027-31. PubMed ID: 12774055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
    Georges GE; Storb R; Thompson JD; Yu C; Gooley T; Bruno B; Nash RA
    Blood; 2000 May; 95(10):3262-9. PubMed ID: 10807798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
    Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
    Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras.
    Kuhr CS; Allen MD; Junghanss C; Zaucha JM; Marsh CL; Yunusov M; Zellme E; Little MT; Torok-Storb B; Storb R
    Transplantation; 2002 May; 73(9):1487-92. PubMed ID: 12023629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunotherapy in canine chimeras.
    Kolb HJ; Günther W; Schumm M; Holler E; Wilmanns W; Thierfelder S
    Transplantation; 1997 Feb; 63(3):430-6. PubMed ID: 9039935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.
    Mapara MY; Kim YM; Marx J; Sykes M
    Transplantation; 2003 Jul; 76(2):297-305. PubMed ID: 12883182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
    Wu BY; Guo KY; Song CY; Yang ; Li D
    Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
    Graves SS; Hogan W; Kuhr CS; Diaconescu R; Harkey MA; Georges GE; Sale GE; Zellmer E; Baran SW; Jochum C; Stone B; Storb R
    Blood; 2007 Jul; 110(1):418-23. PubMed ID: 17369487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
    Georges GE; Lesnikova M; Storb R; Yunusov M; Little MT; Nash RA
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):234-42. PubMed ID: 12720216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
    Storb R; Yu C; Barnett T; Wagner JL; Deeg HJ; Nash RA; Kiem HP; McSweeney P; Seidel K; Georges G; Zaucha JM
    Blood; 1999 Aug; 94(3):1131-6. PubMed ID: 10419907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease.
    Yunusov MY; Georges GE; Storb R; Moore P; Hagglund H; Affolter V; Lesnikova M; Gass MJ; Little MT; Loken M; McKenna H; Storer B; Nash RA
    Transplantation; 2003 Apr; 75(7):933-40. PubMed ID: 12698076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
    Baron F; Sandmaier BM; Zellmer E; Sorror M; Storer B; Storb R
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):813-7. PubMed ID: 16864051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative analysis of donor chimerism in adoptive immunotherapy following allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Sun AN; Zhu ZL; Chang WR; Ruan CG
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):359-62. PubMed ID: 16780733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.